Taysha IPO Presentation Deck

Leadership team and investor syndicate uniquely positioned to deliver on corporate mission Leadership RA Session II Founder, President & CEO Suyash Prasad, MBBS, MSc, MRCP, MRCPCH, FFPM Chief Medical Officer Kamran Alam, CPA, MBA Chief Financial Officer Fred Porter, PhD Chief Technical Officer Mishima Gerhart Chief Regulatory Officer Sean McAuliffe Chief Commercial Officer Jim Rouse Chief Information Officer Emily McGinnis Chief Patient Officer & Head of Government Affairs Dan Janiak, PhD SVP, Corporate Strategy & Business Development Niren Shah, PharmD, MBA VP, Program & Alliance Management and Chief of Staff AUDENTES BIOMARIN SANOFI GENZYME rocket Land gsk & NOVARTIS REATA PTC) bridgebio Steven Gray, PhD Chief Scientific Advisor SANOFI GENZYME PTC) Baxalta REATA REATA NOVARTIS NPS Pharma 10 bridgebio REATA PTC OVATION Mercury Fund NOVARTIS Berge Minassian, MD Chief Medical Advisor Sean Nolan Chairman Paul Manning Phillip Donenberg Advisors RA Session II Sukumar Nagendran, MD UT Southwestern Medical Center. Board of Directors UT Southwestern Medical Center. INTERMUNEREATA PBM CAPITAL AVROBIO REATA TAYSHA 12

View entire presentation